摘要 |
FIELD: medicine, endocrinology, pharmacology, pharmacy.SUBSTANCE: invention relates to a pharmaceutical combined composition used for treatment or prophylaxis of hypertension in patients suffering with diabetes mellitus. The composition comprises AT-antagonist valsartan or its pharmaceutically acceptable salt and calcium channel blocking agent or its pharmaceutically acceptable salt, and pharmaceutically acceptable carrier. The composition elicits synergistic effect and expanded spectrum effect.EFFECT: improved and valuable medicinal properties of composition.10 cl, 3 tbl |